ADMA vs TXT · P/E 22, rev $238.9M vs P/E 19, rev $7.52B
ADMA Biologics Inc (ADMA) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the ADMA and TXT stock pages for the full models.
Not investment advice.